CR6457
Model Information:
multiple liver mets; tumor size: 7 x 1 & 6 x 2. Post Op survival: 1 year.
| Summary | |
|---|---|
| Cancer Type | Colorectal Cancer |
| Grade | T4 N0 Mx V1 Pn0 G2 |
| Stage | NA |
| Ethnicity | Western |
| Gender | M |
| Age | 50 |
| Pathology Diagnosis | multiple liver mets; tumor size: 7 x 1 & 6 x 2. Post Op survival: 1 year. |
| Biopsy Site | Hepatectomy |
| Treatment History | Pre op adjuvant chemotherapy 8 cycles - Oxaliplatin / Capecitabine |
| Pathology QC | Well to moderately differentiated adenocarcinoma (P9). IHC (P8, P11): HepPar1 (+/-), AFP (-), CDX2 (3+), CK20 (1+), CK7 (-) |
| Special Features | NA |
| Mouse Strain | NOD SCID |
| TMA | TMA-HP-CR-030 |
| Viral Status in PDX | NA |
| Available In | CB_CN |
| RNA Seq | P11 |
| Exome Seq | P11 |
